Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.

The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.

Deaths from cancer have been on the decline for years, according to a new report. But there are still some trouble spots.

A recent study conducted by Lona Mody, M.D., M.Sc. at the University of Michigan Medical School found that patients regularly bring multidrug-resistant organisms (bacteria and other microorganisms that have become resistant to certain antibiotics) on their hands when they are discharged from a hospital to a post-acute care facility and often acquire more multidrug-resistant organisms (MDROs) during their time there.

Smartphone apps can do some amazing things — deposit checks, manage stocks and teach French, to name a few. But they may have trouble measuring blood pressure.

An ounce of prevention is a good thing when it comes to HIV infection.

Patients with hemophilia B, a rare, inherited bleeding disorder, may soon have another treatment option.

Sometimes treatments for big diseases come in small packages.

That handy headache remedy sitting in your medicine cabinet may have some other health benefits.

Melanoma and skin moles have long been associated. But there's some new information.